The South Korean office of the Danish pharmaceutical company Novo Nordisk recently requested the local authorities to permit ...

Recent changes at the NIH and other federal agencies make the future of funding unclear for scientists like those at Mayo ...

TeleRare Health® announced it is offering Virtual Genomic Consults across Minnesota, for adult and pediatric patients facing difficulties navigating the diagnosis of their rare or genetics-based ...

PredxBio today announced the official launch of enhanced SpaceIQtm platform to integrate brightfield, spatial proteomics and transcriptomics datasets to deliver a unified, high-resolution view of the ...

Pharmaceutical company Novo Nordisk will expand its production site in Montes Claros, Brazil, creating 600 jobs.

Novo Nordisk (NYSE: NVO), the Danish drugmaker that's been riding high ever since it began putting out Ozempic and Wegovy GLP-1 injectables for treatment of diabetes and weight loss, got another ...

Novo Nordisk (NYSE: NVO), the Danish drugmaker of GLP-1 weight loss drugs Ozempic and Wegovy, slipped 2% through 10:30 a.m. ET Friday after suffering a one-two punch from Reuters and a bank analyst.

Patients flocked to those Ozempic, Wegovy copycats when the branded drugs were in short supply, or if they didn’t have ...

Reuters warns that Novo Nordisk's growth rate is slowing. Singapore bank DBS says the stock is a sell. But at 18 times earnings and with a growth rate of 16% or better, Novo Nordisk actually looks ...